Insight Molecular Diagnostics Inc
(IMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,033 | -72,902 | -27,924 | -18,591 | -10,291 |
| Depreciation Amortization | 472 | 23,916 | 3,954 | 2,586 | 1,222 |
| Accounts receivable | 111 | -575 | -553 | -365 | -685 |
| Accounts payable and accrued liabilities | -2,662 | 297 | 422 | 239 | -21 |
| Other Working Capital | -1,965 | -1,942 | -1,032 | -949 | -1,092 |
| Other Operating Activity | -7,289 | 5,638 | -10,787 | -7,444 | -2,410 |
| Operating Cash Flow | $-8,300 | $-45,568 | $-35,920 | $-24,524 | $-13,277 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -4,340 | -3,538 | -2,679 | -1,561 |
| Net Acquisitions | -1,372 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-1,372 | $-4,340 | $-3,538 | $-2,679 | $-1,561 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -28 | -1,429 | -1,329 | -801 | -385 |
| Common Stock Issued | N/A | 32,843 | 32,843 | 32,454 | 31 |
| Other Financing Activity | 0 | 4,392 | 4,392 | 4,781 | -1 |
| Financing Cash Flow | $-28 | $35,806 | $35,906 | $36,434 | $-355 |
| Beginning Cash Position | 23,203 | 37,305 | 37,305 | 37,305 | 37,305 |
| End Cash Position | 13,503 | 23,203 | 33,753 | 46,536 | 22,112 |
| Net Cash Flow | $-9,700 | $-14,102 | $-3,552 | $9,231 | $-15,193 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,300 | -45,568 | -35,920 | -24,524 | -13,277 |
| Capital Expenditure | N/A | -4,340 | -3,538 | -2,679 | -1,561 |
| Free Cash Flow | -8,300 | -49,908 | -39,458 | -27,203 | -14,838 |